Minireviews
Copyright ©The Author(s) 2022.
World J Orthop. Jun 18, 2022; 13(6): 564-573
Published online Jun 18, 2022. doi: 10.5312/wjo.v13.i6.564
Table 1 Pharmaceutical management of osteoporosis and efficacy
Drug
Dosing
Efficacy
Adverse effects
Bisphosphonates
Alendronate10 mg daily, PO; 70 mg weekly, PORR of 0.55 in postmenopausal women compared to placeboEsophageal irritation; Dyspepsia; Acute phase reaction; Atrial fibrillation; Musculoskeletal pain; Renal toxicity; Atypical fracture; Osteonecrosis of the jaw
Ibandronate2.5 mg daily, PO; 150 mg monthly, PO; 3 mg every 3 mo, IVRR between 0.50 and 0.62 in postmenopausal women compared to placebo
Risedronate5 mg daily, PO; 35 mg weekly, PO; 150 mg monthly, PORR of 0.64 in postmenopausal women compared to placebo
Zoledronate5 mg annually, IV7% increase in spine BMD; RR of 0.23 in postmenopausal women compared to placebo
Rankl inhibitors
Denosumab60 mg every 6 mo, SQ68% decrease in incidence of radiographic vertebral fractures; 9.2% increase in lumbar spine BMDFatigue; Weakness; Diarrhea; Hypophosphatemia
Hormones
Raloxifene (SERM)60 mg daily, PO; 120 mg daily, PORR of 0.65 in postmenopausal women compared to placebo (60 mg); RR of 0.54 in postmenopausal women compared to placebo (120 mg); 2.6% increase in lumbar spine BMD (60 mg); 2.5% in lumbar spine BMD (120 mg)Flu syndrome; Vasodilation; Endometrial cavity fluid; Peripheral edema
Teriparatide (PTH)20 microg daily, SQ; 40 microg daily, SQ65% decrease in fracture risk (20 microg); 69% decrease in fracture risk (40 microg); 9% increase in lumbar spine BMD (20 microg); 13% increase in lumbar spine BMD (40 microg)Nausea; Headache; Dizziness; Leg cramps
Calcitonin (TH)200 mg daily, IN33% decrease in fracture risk; 1%-1.5% increase in lumbar spine BMD Epistaxis; Rhinitis; Ulceration of nasal mucosa; Hypocalcemia
Supplementations
Vitamin D400 IU daily, PO 15% decrease in fracture risk-
Calcium1500 mg daily, PO